Swiss pharmaceutical company Novartis said Friday it has won approval to market its Cosentyx psoriasis treatment in Japan, making it the first country to authorise commercialisation of the drug.
The Japanese decision allows Novartis to sell secukinumab, sold under the name Cosentyx, to adult…
Japan first nation to approve Novartis psoriasis drug
No comments:
Post a Comment